Desq Long
Sign in

Cluster

TENX-2026-09-11-5eaab45462bb

SEC FORM 4CLUSTER · 3 INSIDERS
$132,828.31

TENAX THERAPEUTICS, INC. (TENX)

Purchase of 69,525 shares across 3 reporting persons.

Transaction Code P · Reporting Persons 3

  • Giordano Christopher Thomas, CEOPurchase of 6,000 shares at $1.875 per share.$11,250.00
  • Giordano Christopher Thomas, CEOPurchase of 4,850 shares at $1.8221 per share.$8,837.18
  • STAAB THOMAS R II, Chief Financial OfficerPurchase of 5,675 shares at $1.935 per share.$10,981.13
  • Doogan DeclanPurchase of 53,000 shares at $1.92 per share.$101,760.00

Surfaced by rule: 3 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Sep 11, 2026 · Disclosed Sep 17, 2026FILED +6 DAYS

Source: SEC Form 4 · 0001871714-26-000002 · filed 2026-09-15 · View filing →

Source: SEC Form 4 · 0001193125-26-392319 · filed 2026-09-15 · View filing →

Source: SEC Form 4 · 0001193125-26-394831 · filed 2026-09-17 · View filing →

Permalink →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "TENAX THERAPEUTICS, INC. (TENX)." Disclosed 2026-09-17. https://desqlong.com/cards/cluster-TENX-2026-09-11-5eaab45462bb (retrieved 2026-09-26).